Topical anti-inflammatory eye drops after corneal transplant
Part of Eyes & vision clinical trials.
This study tests whether anti-inflammatory eye drops (nepafenac, an NSAID) can help reduce swelling in the macula (the sharp-vision part of the eye) after certain cornea transplant surgeries. It compares outcomes in adults having DSAEK or DMEK who can safely use the study drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older and can sign consent
- Your planned eye surgery is DSAEK or DMEK (a cornea transplant)
- You’re able to follow study visits and instructions and cooperate during exams
- You do not have a medical reason you can’t use the study medication (like allergy or certain pregnancy-related situations)
- You are not pregnant and will not become pregnant during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three different anti-inflammatory eye drops to see which works best for pain and swelling after cataract surgery. You may join if you are scheduled for cataract surgery only, and you can apply the drops yourself or have help.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
This Phase 2 study tests whether eye drops containing a medicine called N-acetylcysteine (NAC) can reduce damaging “reactive oxygen” in people with advanced Fuchs’ endothelial corneal dystrophy (FECD). It involves people who need a special cornea transplant (DMEK) at the same time as cataract surgery, aiming to improve cornea healing and vision.
This trial tests a type of corneal transplant (DMEK) in people who have had previous eye surgeries, such as vitrectomy or glaucoma surgery. It aims to see if the transplant works well even in these complicated cases.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This trial tests infliximab—given as eye drops—after a first corneal transplant to see if it can improve healing and eye outcomes. It may help people at risk of inflammation after surgery, but it also requires careful screening for infection and medication safety.
Hear when a new Descemet Membrane Endothelial Keratoplasty (DMEK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.